Treat-and-Extend Approach With Ranibizumab Effective in AMD

In patients with neovascular age-related macular disease, a treat-and-extend ranibizumab regimen is not inferior to injections given at fixed intervals, plus it’s more convenient, according to a new clinical trial, according to a Reuters report.

“Our goal in treating macular degeneration, the most common cause of blindness in the western world, is to maximize visual gains and minimize the burden of treatment and visits on patients and their families,” Dr. Peter J. Kertes of Sunnybrook Health Sciences Centre, in Toronto, Canada, told Reuters Health by email.

Read the full article.